The National Workers’ Compensation and Disability Conference & Expo (NWCDC) is the only national conference devoted to workers’ compensation and disability management professionals. This conference also features the largest expo in the workers’ compensation industry. Mitchell | Genex | Coventry will have a dynamic exhibit display on the show floor at booth #527 and is happy to be a returning sponsor for this years’ conference. Please contact your Mitchell | Genex | Coventry representative for more information on this private event.
More stories
5 COVID-19 Security Threats to Know About
Some studies estimate that more than half of the workforce is working from home amidst the COVID-19 crisis, and many companies have already announced plans to allow employees to work remotely even after the threat of the virus has subsided. While working from home has helped social distancing efforts across the country, it has also opened up companies to an onslaught of new security threats.
The COVID-19 Ripple Effect
The global response to the coronavirus has affected all aspects of the claims ecosystem, revealing three early indicators that may have a long-lasting impact.
COVID-19 Affects Treatment in Kentucky and Texas
Kentucky delays medical treatment guidelines implementation and Texas suspends elective surgeries in some counties.
California DWC Publishes Draft Pharmacy Fee Schedule Rule
The California Division of Workers' Compensation (DWC) recently published a long-awaited draft pharmaceutical fee schedule rule.
The Changing Insurance Workforce: Trends and Tips for Adapting [Podcast]
We sat down with Mitchell Vice President of Product Management, Rebecca Morgan, to learn more about the changing insurance workforce and what claim
Specialty Drugs' Impact on Overall Costs in 2019
First Script overall prescription trends saw a slight upward shift in 2019. We’ll take a closer look at some of the specialty medication classes and specific drugs driving this shift and their impacts on overall costs, such as those from the hematological class, HIV medications, and one novel topical eye disorder treatment.